SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-4 - Registration of securities, business combinations:
SEC Accession No. 0001017062-02-000176
Filing Date
2002-01-31
Accepted
2002-01-31 00:00:00
Documents
11

Document Format Files

Seq Description Document Type Size
1 AMGEN INC. FORM S-4 ds4.txt S-4 894541
3 RESTATED PROMOTION AGREEMENT BY IMMUNEX dex101.txt EX-10.1 134246
4 AGREEMENT REGARDING GOVERNANCE &COMMERCIAL MATTERS dex102.txt EX-10.2 16033
5 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS dex233.txt EX-23.3 809
6 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS dex234.txt EX-23.4 871
7 CONSENT OF GOLDMAN, SACHS & CO. dex235.txt EX-23.5 2986
8 CONSENT OF MERRILL LYNCH, PIERCE, FENNER & SMITH dex236.txt EX-23.6 1833
9 FORM OF PROXY OF AMGEN INC. dex994.txt EX-99.4 7025
10 FORM OF PROXY OF IMMUNEX CORPORATION dex995.txt EX-99.5 4313
11 CONSENT OF EDWARD V. FRITZKY dex996.txt EX-99.6 949
12 EMPLOYMENT AGREEMENT dex997.txt EX-99.7 50049
  Complete submission text file 0001017062-02-000176.txt   1116562
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4 | Act: 33 | File No.: 333-81832 | Film No.: 02523881
SIC: 2836 Biological Products, (No Diagnostic Substances)